-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the clues, the investigation team of the State Council in the investigation of Changchun Changsheng Company further found that the company produced the price of non-conforming baibai vaccine related to the same batch of 201605014-01 and 201605014-02 batch number products, a total of 4998 million.
investigation found that Changchun Changsheng company produced batch number 201605014-01 hundred white broken vaccine a total of 252,600, all sold to Shandong Province, has used 247,359, wear and tear, seal 5241. Batch number 201605014-02 hundred white broken vaccine a total of 247,200, of which sold to Shandong 223,800, sealed more than 10,000;
who have been vaccinated against the batch number 201605014-01 produced by Changchun Changsheng Company have been reseeded in accordance with the reseeding work notice of February 6 this year. To date, 76.2 per cent of the total number of children to be reseeded has been completed. Follow-up doses that have not yet been reseeded need to determine the interval according to the actual vaccination of the affected child.
has been vaccinated Changchun Changsheng Company produced batch number 201605014-02 non-conforming white broken vaccine for children's reseeding work, the National Health and Health Commission, the State Drug Administration has made deployment and arrangements.
In order to comprehensively assess the risk of the effectiveness of the 100-white vaccine in Changchun Changsheng Company, the China Food and Drug Inspection Research Institute conducted antigen testing using rapid vaccine testing methods for all batches of the company's validity period, and no abnormalities were found.
is currently conducting an in-depth investigation into the cases of suspected violations of laws and regulations in the production of substandard Baibai-breaking vaccine by Changchun Changsheng Company. Violations and personnel shall be severely punished in accordance with the law, and local governments and competent departments with supervisory responsibilities shall be severely punished for dereliction of duty, dereliction of duty, negligence or inaction. The results of the investigation and prosecution shall be announced to the public in a timely manner (Xinhua News Agency)